Medicines NZ hopes country can roll out COVID-19 vaccines early

19 January 2021 - Medical professionals are hopeful New Zealand is in a position to roll out COVID-19 vaccines early. ...

Read more →

How NZ is preparing for the biggest vaccine roll-out in history

17 January 2021 - “When will we get a vaccine for COVID-19?” It has been the question on everyone’s lips for ...

Read more →

COVID-19: NZ vaccine timeline remains the same in light of new variant strains

13 January 2021 - New Zealand does not have any plans to fast-track its Covid-19 vaccine roll-out in light of ...

Read more →

From 1 February 2021 pre-COVID-19 Special Authority criteria will be reinstated

12 January 2020 - The temporary changes will remain in place for any Special Authority applications for the relevant medicines made ...

Read more →

Decision to widen access to valganciclovir for transplant patients

12 January 2021 - PHARMAC is pleased to announce a decision to widen access to valganciclovir for use after lung ...

Read more →

Evaluating New Zealanders’ values for drug coverage decision-making: trade-offs between treatments for rare and common conditions

8 January 2021 - The objectives of this study were to measure the relative societal importance of values of New Zealanders ...

Read more →

Crohn's disease and colitis sufferers plead with PHARMAC to fund new drug

5 January 2021 - Sufferers of Crohn's disease and colitis are pleading with PHARMAC to fund a drug that's available ...

Read more →

New Zealand Pharmaceutical Schedule - 1 January 2021

1 January 2021 - The January 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Kiwis going into debt to pay for drugs other countries fund

21 December 2020 - An internal stoush at the drug-buying agency PHARMAC has blocked funding for a life-extending drug for bowel ...

Read more →

PHARMAC to fund new diabetes medicines with amended Special Authority criteria

21 December 2020 - PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders ...

Read more →

Year in review

16 December 2020 - PHARMAC claims it funded 14 new medicines, including six new cancer medicines, and widened access to ...

Read more →

Diabetes drugs delay shows problem with PHARMAC’s funding model, doctor claims

14 December 2020 - Pharmac’s decision to delay funding approval for two new diabetes drugs has highlighted the shortcomings of ...

Read more →

Proposal to widen access to febuxostat for prevention of tumour lysis syndrome

10 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to febuxostat tablets. ...

Read more →

'We're feeling broken': Taranaki father of six dies after battle for cancer drug funding

10 December 2020 - A Taranaki father who fought to get vital cancer drugs funded by the Government has lost his ...

Read more →

PHARMAC diabetes drugs delay 'bewildering', 'worse than disappointing' - doctors

7 December 2020 - A decision by PHARMAC to defer the approval of two new drugs for the treatment of diabetes ...

Read more →